Hans Sauer

Professor Sauer is Associate General Counsel for Intellectual Property for the Biotechnology Industry Organization, a major trade association representing over 1,100 biotechnology companies from the medical, agricultural, environmental and industrial sector. At BIO, Professor Sauer advises the organization’s board of directors, amicus committee, and various staff committees on patent and other intellectual property-related matters. Prior to his current position, Professor Sauer was Chief Patent Counsel for MGI Pharma, Inc., and Senior Patent Counsel for Guilford Pharmaceuticals Inc. Professor Sauer has 13 years of professional in-house experience in the biotechnology industry, where he worked on several drug development programs, being responsible for patent prosecution and portfolio oversight, clinical trial health information privacy, and sales and marketing legal compliance. Professor Sauer frequently speaks on behalf of the Biotechnology Industry Organization on topics such as patent reform, Patent and Trademark Office rules, and the impact of judicial developments on the biotechnology industry.